Identification of proteins deregulated by platinum-based chemotherapy as novel biomarkers and therapeutic targets in non-small cell lung cancer

HIGHLIGHTS

  • who: Sarah-Louise Ryan from the Veneto Institute of (IRCCS), Italy University of Naples Federico II, Italy have published the research: Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer, in the Journal: (JOURNAL)
  • what: The authors report the number of signaling proteins in the interactome curated from CanSAR for the up and downregulated proteins. While at an early exploratory stage, the study provides a platform for future preclinical evaluation. The study has also identified the deregulated proteins CLUH and 3′-phosphoadenosine 5′-phosphosulfate . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?